Skip to search.
 FTSE 100 Up 0.26%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
9.23 Up 0.12(1.32%) 22 May 21:00
Add to Portfolio
Prev Close:9.11
Open:9.13
Bid:9.11 x 300
Ask:N/A
1y Target Est:15.81
Beta:1.2
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:9.05 - 9.27
52wk Range:2.65 - 16.87
Volume:4,080,971
Avg Vol (3m):3,622,060
Market Cap:1.09b
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNUp 1.32%1.09b
GSKDown 0.66%109.30b
JNJDown 1.04%281.05b
RHHBYDown 0.94%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.74
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-0.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback